메뉴 건너뛰기




Volumn 4, Issue 2, 2009, Pages 244-248

WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: Involvement of p38 MAP kinase

Author keywords

Astrocytes; CX3CL1; MAP kinase

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 2 RECEPTOR; FRACTALKINE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38;

EID: 67649128493     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-009-9147-5     Document Type: Article
Times cited : (34)

References (15)
  • 3
    • 0037218316 scopus 로고    scopus 로고
    • Therapeutic potential of cannabinoids in CNS disease
    • DOI 10.2165/00023210-200317030-00004
    • JL Croxford 2003 Therapeutic potential of cannabinoids in CNS disease CNS Drugs 17 179 202 (Pubitemid 36286534)
    • (2003) CNS Drugs , vol.17 , Issue.3 , pp. 179-202
    • Croxford, J.L.1
  • 4
    • 0037397037 scopus 로고    scopus 로고
    • Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212
    • DOI 10.1172/JCI200317652
    • JL Croxford SD Miller 2003 Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212 J Clin Invest 111 1231 1240 (Pubitemid 36519940)
    • (2003) Journal of Clinical Investigation , vol.111 , Issue.8 , pp. 1231-1240
    • Croxford, J.L.1    Miller, S.D.2
  • 7
    • 0033178775 scopus 로고    scopus 로고
    • Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: Involvement of interleukin-1β production by microglia
    • S Hu H Ali WS Sheng LC Ehrlich PK Peterson CC Chao 1999 Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: involvement of interleukin-1beta production by microglia J Neurosci 19 6468 6474 (Pubitemid 29347446)
    • (1999) Journal of Neuroscience , vol.19 , Issue.15 , pp. 6468-6474
    • Hu, S.1    Ali, H.2    Sheng, W.S.3    Ehrlich, L.C.4    Peterson, P.K.5    Chao, C.C.6
  • 9
    • 18844400058 scopus 로고    scopus 로고
    • Cannabinoid-based drugs as anti-inflammatory therapeutics
    • DOI 10.1038/nri1602
    • TW Klein 2005 Cannabinoid-based drugs as anti-inflammatory therapeutics Nat Rev Immunol 5 400 411 (Pubitemid 40685989)
    • (2005) Nature Reviews Immunology , vol.5 , Issue.5 , pp. 400-411
    • Klein, T.W.1
  • 12
    • 0035795072 scopus 로고    scopus 로고
    • Enhanced expression of fractalkine in HIV-1 associated dementia
    • DOI 10.1016/S0165-5728(01)00262-4, PII S0165572801002624
    • CF Pereira J Middel G Jansen J Verhoef HS Nottet 2001 Enhanced expression of fractalkine in HIV-1 associated dementia J Neuroimmunol 115 168 175 (Pubitemid 32245665)
    • (2001) Journal of Neuroimmunology , vol.115 , Issue.1-2 , pp. 168-175
    • Pereira, C.F.1    Middel, J.2    Jansen, G.3    Verhoef, J.4    Nottet, H.S.L.M.5
  • 13
    • 13244283049 scopus 로고    scopus 로고
    • Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
    • DOI 10.1002/glia.20108
    • WS Sheng S Hu X Min GA Cabral JR Lokensgard PK Peterson 2005 Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes Glia 49 211 219 (Pubitemid 40188500)
    • (2005) GLIA , vol.49 , Issue.2 , pp. 211-219
    • Sheng, W.S.1    Hu, S.2    Min, X.3    Cabral, G.A.4    Lokensgard, J.R.5    Peterson, P.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.